Oramed Pharmaceuticals Inc. Common Stock (ORMP)

Typically moves ±8.43% on earnings
EARNINGS ANALYTICS
search

Oramed Pharmaceuticals Inc. Common Stock (ORMP) has only 2 recorded earnings events on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was +14.76% (Nov 10, 2022) and its biggest decline was -2.1% (Nov 17, 2025).

Earnings reactions

How ORMP moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

2

Avg Abs. Movement

±8.43%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Nov 17, 2025 ☀ PRE -2.1% open_in_new
Nov 10, 2022 ☽ POST +14.76% open_in_new
event

Earnings Count

2

Total earnings in dataset

trending_up

Avg Abs. Movement

±8.43%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 17 →
17
Funds holding
$13876162
Total value held
Buying
15 added · 1 reduced
Blackrock, Inc.
$7735015 +1644.31%
Goldman Sachs Group Inc
$1218339 NEW BUY
State Street Corp
$1164501 NEW BUY
Northern Trust Corp
$889465 NEW BUY
Wells Fargo & Company/Mn
$798458 +5.34%

Frequently asked about ORMP earnings

How much does ORMP stock move after earnings? expand_more

Over 2 reports, ORMP has moved an average of ±8.43% the session after earnings, closing higher 50.0% of the time.

What was ORMP's biggest post-earnings move? expand_more

ORMP's largest post-earnings gain on record was +14.76% on Nov 10, 2022, and its largest decline was -2.1% on Nov 17, 2025.

Where can I find Oramed Pharmaceuticals Inc. Common Stock's SEC filings? expand_more

All of Oramed Pharmaceuticals Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.